Predictive Power Estimation Algorithm (PPEA) - A New Algorithm to Reduce Overfitting for Genomic Biomarker Discovery
暂无分享,去创建一个
Robert A. Jolly | Keith M. Goldstein | Vladimir N. Uversky | George H. Searfoss | K. Goldstein | V. Uversky | Jiangang Liu | S. Li | G. Searfoss | K. Dunker | Shuyu Li | Jiangang Liu | Craig E. Thomas | R. Jolly | Tao Wei | Aaron T. Smith | Keith Dunker | T. Wei
[1] B. Mougin,et al. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. , 2004, Journal of biotechnology.
[2] J. Ozer,et al. The current state of serum biomarkers of hepatotoxicity. , 2008, Toxicology.
[3] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[4] I. Bross. How to use Ridit Analysis , 1958 .
[5] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[6] Gert R. G. Lanckriet,et al. Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. , 2005, Genome research.
[7] Edward R. Dougherty,et al. The peaking phenomenon in the presence of feature-selection , 2008, Pattern Recognit. Lett..
[8] P. Seeburg,et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.
[9] Xuegong Zhang,et al. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data , 2006, BMC Bioinformatics.
[10] Isabelle Guyon,et al. An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..
[11] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Pascussi,et al. Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. , 2008, Molecular pharmaceutics.
[13] Chao Sima,et al. Performance of Feature Selection Methods , 2009, Current genomics.
[14] Chuan Lu,et al. An investigation into the population abundance distribution of mRNAs, proteins, and metabolites in biological systems , 2009, Bioinform..
[15] Nicoletta Dessì,et al. An evolutionary method for combining different feature selection criteria in microarray data classification , 2009 .
[16] M. Fielden,et al. A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity , 2005, Toxicologic pathology.
[17] J. Eun,et al. Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. , 2008, Toxicology.
[18] A. Nobel,et al. Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .
[19] D. Adams,et al. Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.
[20] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[21] Ron Kohavi,et al. Irrelevant Features and the Subset Selection Problem , 1994, ICML.
[22] Lue Ping Zhao,et al. Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. , 2005, Chemical research in toxicology.
[23] T. H. Bø,et al. New feature subset selection procedures for classification of expression profiles , 2002, Genome Biology.
[24] P. Bork,et al. Proteome survey reveals modularity of the yeast cell machinery , 2006, Nature.
[25] Gary W. Donaldson. Ridit scores for analysis and interpretation of ordinal pain data , 1998, European journal of pain.
[26] D. Ransohoff. Bias as a threat to the validity of cancer molecular-marker research , 2005, Nature reviews. Cancer.
[27] F. Sistare,et al. Preclinical Predictors of Clinical Safety: Opportunities for Improvement , 2007, Clinical pharmacology and therapeutics.
[28] Nir Friedman,et al. Tissue classification with gene expression profiles , 2000, RECOMB '00.
[29] M. Fielden,et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.
[30] J. E. Peterson. Biliary Hyperplasia and Carcinogenesis in Chronic Liver Damage Induced in Rats by Phomopsin , 1990, Pathology.
[31] M. Fielden,et al. The liver pharmacological and xenobiotic gene response repertoire , 2008, Molecular systems biology.
[32] J. Stevens,et al. Strategic applications of toxicogenomics in early drug discovery. , 2008, Current opinion in pharmacology.
[33] Monilola A. Olayioye,et al. Update on HER-2 as a target for cancer therapy: Intracellular signaling pathways of ErbB2/HER-2 and family members , 2001, Breast Cancer Research.
[34] D. Ransohoff. Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.
[35] Ron Kohavi,et al. Wrappers for Feature Subset Selection , 1997, Artif. Intell..
[36] Shibing Deng,et al. Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays. , 2007, BioTechniques.
[37] Sanmay Das,et al. Filters, Wrappers and a Boosting-Based Hybrid for Feature Selection , 2001, ICML.
[38] J. Concato,et al. A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.
[39] Charles E McCulloch,et al. Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.
[40] Philip G Hewitt,et al. Acute hepatotoxicity: a predictive model based on focused illumina microarrays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[41] Tieliu Shi,et al. Consistency of predictive signature genes and classifiers generated using different microarray platforms , 2010, The Pharmacogenomics Journal.
[42] D. Mendrick,et al. Genomic and genetic biomarkers of toxicity. , 2008, Toxicology.
[43] R. E. Wilson,et al. Blood gene expression signatures predict exposure levels , 2007, Proceedings of the National Academy of Sciences.
[44] A. Dunker,et al. Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data , 2008, BMC Medical Genomics.